Drug intelligence / Profile preview

Jufex Forte

Development stage: Unknown
Lead developer: Aimil
Administration: Oral

Overview

Jufex Forte is an Ayurvedic polyherbal formulation developed by Aimil Pharmaceuticals, designed to provide relief from symptoms associated with upper respiratory tract infections, including cold and cough. Administered as an oral syrup, it contains a synergistic blend of traditional botanicals such as Jufa (Hyssopus officinalis), Vasa (Justicia adhatoda), Kaiphal (Myrica esculenta), Tulsi (Ocimum sanctum), and honey. The formulation is marketed for its antiviral, mucolytic, and antihistaminic properties, helping to clear mucus, soothe sore throats, and strengthen respiratory function. It is a non-alcoholic, non-sedative, and non-addictive treatment indicated for conditions such as childhood and chronic bronchitis, laryngitis, pharyngitis, and smoker's cough.

Brand names: Jufex Forte
Other names: Jufex Forte Syrup

Beyond the preview

Go deeper on Jufex Forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jufex Forte.

Explore the full profile